NOVARTIS-CLCZ696B2314



A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction
sacubitril/valsartan
CLCZ696B2314
NCT01035255
Heart Failure, Chronic (CHF)
Phase 3
 
June 2016